Abstract
Home blood pressure (BP) monitoring is a more accurate diagnostic modality for hypertension than office BP measurement. Nonetheless, home BP measurement (HBPM) must be performed at specific times (morning and evening) under specific conditions (e.g., with the subject at rest), and thus it is of limited use for detecting various forms of masked hypertension, such as daytime ambulatory hypertension and nighttime hypertension, which are better detected by ambulatory BP monitoring (ABPM). Indeed, if we use the same threshold of 135/85 mmHg for the diagnosis of hypertension by both HBPM and daytime ABPM, we find that HBPM misdiagnoses a significant number of cases of masked hypertension. On the other hand, HBPM has the important advantage of including a greater number of BP readings due to the use of repeated home measurements. In addition, out-of-office BP is not stable, but rather changes with the various day-by-day individual and environmental conditions. The diagnosis of hypertension and uncontrolled hypertension on medication, which is affected by real-world stressors and other conditions, could be detected more immediately by repeated self-measured HBPM than by the intermittent measurements used for office and/or ABPM.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104.
Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and Management of High Blood Pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Hypertension. 2018;71:1269–324.
Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 2014;37:253–390.
Park S, Buranakitjaroen P, Chen CH, Chia YC, Divinagracia R, Hoshide S, et al. Expert panel consensus recommendations for home blood pressure monitoring in Asia: the Hope Asia network. J Hum Hypertens. 2018;32:249–58.
Kario K, Park S, Buranakitjaroen P, Chia YC, Chen CH, Divinagracia R, et al. Guidance on home blood pressure monitoring: a statement of the HOPE Asia Network. J Clin Hypertens. 2018;20:456–61.
Pierdomenico SD, Pierdomenico AM, Coccina F, Clement DL, De Buyzere ML, De Bacquer DA, et al. Prognostic value of masked uncontrolled hypertension. Hypertension. 2018;72:862–9.
Kario K, Thijs L, Staessen JA. Blood pressure measurement and treatment decisions: masked and white coat hypertension. Circ Res. 2019;124(7):990–1008.
Banegas JR, Ruilope LM, de la Sierra A, Vinyoles E, Gorostidi M, de la Cruz JJ, et al. Relationship between clinic and ambulatory blood-pressure measurements and mortality. N Engl J Med. 2018;378:1509–20.
Stergiou GS, Bliziotis IA. Home blood pressure monitoring in the diagnosis and treatment of hypertension: a systematic review. Am J Hypertens. 2011;24:123–34.
Kario K. Global impact of 2017 American Heart Association/American College of Cardiology Hypertension Guidelines: a perspective from Japan. Circulation. 2018;137:543–5.
Satoh M, Asayama K, Murakami T, Kikuya M, Metoki H, Imai Y, et al. Stroke risk due to partial white-coat or masked hypertension based on the ACC/AHA guideline's blood pressure threshold: the Ohasama study. Hypertens Res. 2019;42:120–2.
Stergiou GS, Kollias A, Zeniodi M, Karpettas N, Ntineri A. Home blood pressure monitoring: primary role in hypertension management. Curr Hypertens Rep. 2014;16(8):462.
Stergiou GS, Ntineri A. The optimal schedule for self-home blood pressure monitoring. J Hypertens. 2015;33(4):693–7.
Kang YY, Li Y, Huang QF, Song J, Shan XL, Dou Y, Xu XJ, Chen SH, Wang JG. Accuracy of home versus ambulatory blood pressure monitoring in the diagnosis of white-coat and masked hypertension. J Hypertens. 2015;33:1580–7.
Gill P, Haque MS, Martin U, Mant J, Mohammed MA, Heer G, et al. Measurement of blood pressure for the diagnosis and management of hypertension in different ethnic groups: one size fits all. BMC Cardiovasc Disord. 2017;17:55.
Anstey DE, Muntner P, Bello NA, Pugliese DN, Yano Y, Kronish IM, et al. Diagnosing masked hypertension using ambulatory blood pressure monitoring, home blood pressure monitoring, or both? Hypertension. 2018;72:1200–7.
Satoh M, Asayama K, Kikuya M, Inoue R, Metoki H, Hosaka M, et al. Long-term stroke risk due to partial white-coat or masked hypertension based on home and ambulatory blood pressure measurements: the Ohasama study. Hypertension. 2016;67:48–55.
Andreadis EA, Agaliotis G, Kollias A, Kolyvas G, Achimastos A, Stergiou GS. Night-time home versus ambulatory blood pressure in determining target organ damage. J Hypertens. 2016;34:438–44.
Kario K. Nocturnal hypertension: new technology and evidence. Hypertension. 2018;71:997–1009.
Asayama K, Fujiwara T, Hoshide S, Ohkubo T, Kario K, Stergiou GS, et al. Nocturnal blood pressure measured by home devices: evidence and perspective for clinical application. J Hypertens. 2019;37(5):905–16.
Imai Y, Asayama K, Fujiwara S, Saito K, Sato H, Haga T, et al. Development and evaluation of a home nocturnal blood pressure monitoring system using a wrist-cuff device. Blood Press Monit. 2018;23:318–26.
Ishikawa J, Hoshide S, Eguchi K, Ishikawa S, Shimada K, Kario K, et al. Nighttime home blood pressure and the risk of hypertensive target organ damage. Hypertension. 2012;60:921–8.
Kollias A, Andreadis E, Agaliotis G, Kolyvas GN, Achimastos A, Stergiou GS. The optimal night-time home blood pressure monitoring schedule: agreement with ambulatory blood pressure and association with organ damage. J Hypertens. 2018;36:243–9.
Fujiwara T, Nishizawa M, Hoshide S, Kanegae H, Kario K. Comparison of different schedules of nocturnal home blood pressure measurement using an information/communication technology-based device in hypertensive patients. J Clin Hypertens. 2018;20:1633–41.
Kario K, Wang JG. Could 130/80 mm hg be adopted as the diagnostic threshold and management goal of hypertension in consideration of the characteristics of Asian populations? Hypertension. 2018;71:979–84.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG, part of Springer Nature
About this chapter
Cite this chapter
Kario, K. et al. (2020). Diagnostic Value of Home Blood Pressure. In: Stergiou, G., Parati, G., Mancia, G. (eds) Home Blood Pressure Monitoring. Updates in Hypertension and Cardiovascular Protection. Springer, Cham. https://doi.org/10.1007/978-3-030-23065-4_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-23065-4_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-23064-7
Online ISBN: 978-3-030-23065-4
eBook Packages: MedicineMedicine (R0)